Literature DB >> 1127583

Influence of topical anesthesia on tear dynamics and ocular drug bioavailability in albino rabbits.

T F Patton, J R Robinson.   

Abstract

The bioavailability of topically applied ocular drugs is very poor, due largely to drug loss through drainage and tear turnover. The use of high viscosity solutions or solid matrixes to delay or eliminate drainage is the usual approach for decreasing drug loss but the alternative approach of chemically reducing tear turnover and/or solution drainage has not been investigated. By means of a simple isotopic dilution technique, using radioactive technetium sulfur colloid, the quantitative influence of topical anesthetics on tear production and instilled solution drainage was determined. The reduction in the rate of tear turnover and solution drainage varies for different anesthetics and is dose dependent. The implication of these results for some long accepted clinical procedures is discussed, and questions are raised regarding the present understanding of the mechanisms of tear production. Quantitation of precorneal drug loss through instilled solution drainage and tear turnover permits the establishment of a baseline for ocular drug bioavailability. Aqueous humor drug concentration versus time profiles of radioactive pilocarpine nitrate were obtained, both in the presence and absence of topical anesthesia. The results verify the importance of tear turnover and instilled solution drainage as a major route of drug loss in the eye. Moreover, the success of the present study in improving ocular drug bioavailability by the chemical approach of repressing solution drainage and tear turnover suggests that this approach is viable for improving drug bioavailability.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1127583     DOI: 10.1002/jps.2600640215

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  5 in total

1.  mRNA expression of metabolic enzymes in human cornea, corneal cell lines, and hemicornea constructs.

Authors:  Christian Kölln; Stephan Reichl
Journal:  J Ocul Pharmacol Ther       Date:  2011-12-23       Impact factor: 2.671

2.  Low-molecular-weight sodium hyaluronate in the treatment of bacterial corneal ulcers.

Authors:  S A Gandolfi; A Massari; J G Orsoni
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

3.  Frequent association of delayed tear clearance in ocular irritation.

Authors:  P Prabhasawat; S C Tseng
Journal:  Br J Ophthalmol       Date:  1998-06       Impact factor: 4.638

4.  Ocular pharmacokinetic models of clonidine-3H hydrochloride.

Authors:  C H Chiang; R D Schoenwald
Journal:  J Pharmacokinet Biopharm       Date:  1986-04

5.  Photography-based method for assessing fluorescein clearance test in dogs.

Authors:  Arianne Pontes Oriá; Miriam Flores Rebouças; Emanoel Martins Filho; Francisco de Assis Dórea Neto; Ana Cláudia Raposo; Lionel Sebbag
Journal:  BMC Vet Res       Date:  2018-09-03       Impact factor: 2.741

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.